Publication | Closed Access

The leukotriene receptor antagonist montelukast in the treatment of non-alcoholic steatohepatitis: A proof-of-concept, randomized, double-blind, placebo-controlled trial

InflammationMedicinePlacebo-controlled TrialNon-alcoholic SteatohepatitisPharmacotherapyHepatotoxicityLiver DiseaseFatty Liver DiseasePharmacologyDrug-induced Liver Injury